CIHPF yields 8.00% · JNJ yields 2.14%● Live data
📍 CIHPF pulled ahead of the other in Year 1
Combined, CIHPF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CIHPF + JNJ for your $10,000?
CB Industrial Product Holding Berhad, an investment holding company, manufactures and sells palm oil mill equipment and related spare parts in Indonesia, Malaysia, Papua New Guinea, Central America, Africa, Liberia, and internationally. The company operates through Plantation and Milling, Equipment and Engineering, Refinery, Special Purpose Vehicles, and Investing segments. Its products include screw presses, digesters, sludge centrifuges, and king crackers. The company also cultivates oil palm; and engages in trading and processing crude palm oil, crude palm kernel oil, sludge palm oil, and refined bleached deodorized palm oil. In addition, it is involved in designing, fabricating, manufacturing, retrofitting, and maintaining works of various special purpose vehicles, such as firefighting and rescue vehicles, and ambulances. Further, the company designs, manufactures, installs, tests, commissions, and maintains works of boilers and unfired pressure vessels. Additionally, it engages in the provision of services for engineering support, mechanical fabrication, commissioning, and other contracting works for palm oil mills; trading of palm oil mill processing equipment; supply and sale of spare parts for palm oil mills; and design, fabrication, supply, procurement, maintenance, and service of aviation related equipment. CB Industrial Product Holding Berhad was founded in 1980 and is based in Shah Alam, Malaysia.
Full CIHPF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.